CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...

Peripheral Nerve Stimulation — The Nalu PNS System is indicated for pain management in adults who have severe chronic intractable pain of peripheral nerve origin as the sole mitigating agent or as an ...

Boston Scientific has acquired Nalu Medical for around $533m, broadening the therapeutic scope of the medtech giant’s neuromodulation portfolio. California-based Nalu’s Neurostimulation System is ...

Boston Scientific (NYSE:BSX) will acquire Nalu Medical for $533M in cash for the equity it does not already own. Nalu specializes in peripheral nerve stimulation devices for treating chronic pain in ...

Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...

Centennial Spine and Pain joined us at the New Mexico Living studio on Monday for our weekly health segment. This week, Dr. John Watkins told us all about peripheral nerve stimulators – what they are, ...

Boston Scientific Corp. moved to acquire the balance of Nalu Medical Inc. in a $533 million cash deal, expanding its chronic pain portfolio with the addition of peripheral nerve stimulation. The Nalu ...

Boston Scientific has plans to acquire medtech company Nalu Medical, which specializes in developing and commercializing minimally invasive chronic pain solutions. Boston Scientific has been a Nalu ...

CARLSBAD, Calif.--(BUSINESS WIRE)-- Nalu Medical, Inc. (“Nalu”) announced today the appointment of Raymond W. Cohen to serve as chairman of its board of directors. Following the sale of Axonics, Cohen ...